查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球計量原子吸入器市場——行業分析、規模、份額、增長、趨勢和預測，2022-2031 年
市場調查報告書
商品編碼
1229577

全球計量原子吸入器市場——行業分析、規模、份額、增長、趨勢和預測，2022-2031 年

Metered Dose Inhalers Market (Product Type: Manual Actuated pMDIs and Breath Actuated pMDIs; Disease Indication: Asthma, COPD, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 216 Pages | 商品交期: 2-10個工作天內

價格

以 2022 年為基準年，2031 年為預測年，本報告介紹了 2017 年至 2031 年全球計量吸入器市場的收入。它還介紹了 2022 年至 2031 年全球計量吸入器市場的複合年增長率 (CAGR %)。

本報告是廣泛研究的結果。在初步研究中，分析師對主要思想領袖、行業領袖和輿論製造者進行了訪談，開展了大量研究工作。在二次研究中，我們通過參考主要公司的產品資料、年報、新聞稿和相關文件確定了計量吸入器市場。

該報告深入探討了全球計量吸入器市場的競爭格局。已經確定了在全球計量吸入器市場運營的主要參與者，並且對這些公司中的每一家都進行了不同屬性的分析。公司概況、財務狀況、近期發展和 SWOT 是本報告中介紹的全球計量吸入器市場參與者的屬性。

目錄

第一章 前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目的
  • 調查亮點

第二章前提條件和研究方法

3. 執行摘要：計量吸入器的全球市場

第四章市場概況

  • 介紹
    • 定義
    • 行業的演變與發展
  • 概述
  • 市場動態
    • 促進者
    • 抑製劑
    • 機會
  • 2017-2031 年全球計量吸入器市場分析與預測
    • 市場收入預測
  • 波特五力分析

第 5 章關鍵見解

  • 呼吸道疾病流行病學
  • 技術進步
  • 重大併購（Merger/Acquisition
  • COVID-19 大流行對行業的影響（價值鍊和短期、中期和長期影響）。

第六章按產品類型分列的計量原子吸入器的全球市場分析與預測

  • 介紹和定義
  • 重大發現/發展
  • 2017-2031 年按產品類型劃分的市場價值預測
    • 手動pMDI
    • 呼吸致動器 pMDI
  • 市場吸引力分析：按產品類型

第七章按適應症分列的計量吸入器全球市場分析與預測

  • 介紹和定義
  • 重大發現/發展
  • 市場價值預測：按疾病適應症分類，2017-2031 年
    • 支氣管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 市場吸引力分析：按疾病和適應症

8 全球計量原子吸入器市場分析及分銷渠道預測

  • 介紹和定義
  • 重大發現/發展
  • 2017-2031 年各分銷渠道的市場價值預測
    • 醫院藥房
    • 零售藥店
    • 在線藥店
  • 市場吸引力分析：按分銷渠道

第 9 章按地區分列的計量原子吸入器的全球市場分析和預測

  • 主要發現
  • 2017-2031 年各地區市場價值預測
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 市場吸引力分析：按地區

第 10 章北美計量原子吸入器市場分析與預測

  • 介紹
    • 主要發現
  • 2017-2031 年按產品類型劃分的市場價值預測
    • 手動pMDI
    • 呼吸致動器 pMDI
  • 市場價值預測：按疾病適應症分類，2017-2031 年
    • 支氣管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分銷渠道的市場價值預測
    • 醫院藥房
    • 零售藥店
    • 在線藥店
  • 市場價值預測：按國家/地區劃分，2017-2031 年
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按產品類型
    • 按疾病 按適應症
    • 按分銷渠道
    • 按國家

第 11 章歐洲計量吸入器市場分析與預測

  • 介紹
    • 主要發現
  • 2017-2031 年按產品類型劃分的市場價值預測
    • 手動pMDI
    • 呼吸致動器 pMDI
  • 市場價值預測：按疾病適應症分類，2017-2031 年
    • 支氣管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分銷渠道的市場價值預測
    • 醫院藥房
    • 零售藥店
    • 在線藥店
  • 2017-2031 年按國家/地區劃分的市場價值預測
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 市場吸引力分析
    • 按產品類型
    • 按疾病 按適應症
    • 按分銷渠道
    • 按國家/地區

第 12 章亞太計量原子吸入器市場分析與預測

  • 介紹
    • 主要發現
  • 2017-2031 年按產品類型劃分的市場價值預測
    • 手動pMDI
    • 呼吸致動器 pMDI
  • 市場價值預測：按疾病適應症分類，2017-2031 年
    • 支氣管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分銷渠道的市場價值預測
    • 醫院藥房
    • 零售藥店
    • 在線藥店
  • 2017-2031 年按國家/地區劃分的市場價值預測
    • 中國
    • 日本
    • 印度
    • 澳大利亞/新西蘭
    • 亞太其他地區
  • 市場吸引力分析
    • 按產品類型
    • 按疾病 按適應症
    • 按分銷渠道
    • 按國家/地區

第 13 章拉丁美洲計量原子吸入器市場分析與預測

  • 介紹
    • 主要發現
  • 2017-2031 年按產品類型劃分的市場價值預測
    • 手動pMDI
    • 呼吸致動器 pMDI
  • 市場價值預測：按疾病適應症分類，2017-2031 年
    • 支氣管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分銷渠道的市場價值預測
    • 醫院藥房
    • 零售藥店
    • 在線藥店
  • 2017-2031 年按國家/地區劃分的市場價值預測
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 市場吸引力分析
    • 按產品類型
    • 按疾病 按適應症
    • 按分銷渠道
    • 按國家/地區

第 14 章中東和非洲計量原子吸入器市場分析與預測

  • 介紹
    • 主要發現
  • 2017-2031 年按產品類型劃分的市場價值預測
    • 手動pMDI
    • 呼吸致動器 pMDI
  • 市場價值預測：按疾病適應症分類，2017-2031 年
    • 支氣管哮喘
    • 慢性阻塞性肺疾病
    • 其他
  • 2017-2031 年各分銷渠道的市場價值預測
    • 醫院藥房
    • 零售藥店
    • 在線藥店
  • 2017-2031 年按國家/地區劃分的市場價值預測
    • 海灣合作委員會國家
    • 南非
    • 其他中東/非洲地區
  • 市場吸引力分析
    • 按產品類型
    • 按疾病 按適應症
    • 按分銷渠道
    • 按國家/地區

第十五章競爭格局

  • 市場競爭對手 - 競爭矩陣（按層級，按公司規模）
  • 市場份額分析：按公司分類（2021 年）
  • 公司簡介
    • AstraZeneca
    • Cipla Limited
    • Novartis AG
    • Merck & Co., Inc.
    • Sanofi
    • Boehringer Ingelheim
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Hikma Pharmaceuticals plc
    • GlaxoSmithKline
Product Code: TMRGL32174

The report provides revenue of the global metered dose inhalers market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global metered dose inhalers market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the metered dose inhalers market.

The report delves into the competitive landscape of the global metered dose inhalers market. Key players operating in the global metered dose inhalers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global metered dose inhalers market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Metered Dose Inhalers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Metered Dose Inhalers Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Forces Analysis

5. Key Insights

  • 5.1. Respiratory Disease Epidemiology
  • 5.2. Technological Advancements
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Metered Dose Inhalers Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Manual Actuated pMDIs
    • 6.3.2. Breath Actuated pMDIs
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Metered Dose Inhalers Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 7.3.1. Asthma
    • 7.3.2. COPD
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Disease Indication

8. Global Metered Dose Inhalers Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Metered Dose Inhalers Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Metered Dose Inhalers Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Manual Actuated pMDIs
    • 10.2.2. Breath Actuated pMDIs
  • 10.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 10.3.1. Asthma
    • 10.3.2. COPD
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Disease Indication
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Metered Dose Inhalers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Manual Actuated pMDIs
    • 11.2.2. Breath Actuated pMDIs
  • 11.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 11.3.1. Asthma
    • 11.3.2. COPD
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Disease Indication
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Metered Dose Inhalers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Manual Actuated pMDIs
    • 12.2.2. Breath Actuated pMDIs
  • 12.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 12.3.1. Asthma
    • 12.3.2. COPD
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Disease Indication
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Metered Dose Inhalers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Manual Actuated pMDIs
    • 13.2.2. Breath Actuated pMDIs
  • 13.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 13.3.1. Asthma
    • 13.3.2. COPD
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Disease Indication
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Metered Dose Inhalers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Manual Actuated pMDIs
    • 14.2.2. Breath Actuated pMDIs
  • 14.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 14.3.1. Asthma
    • 14.3.2. COPD
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Disease Indication
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. AstraZeneca
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Type Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Cipla Limited
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Type Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Novartis AG
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Type Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Merck & Co., Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Type Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Sanofi
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Type Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. Boehringer Ingelheim
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Type Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. Teva Pharmaceutical Industries Ltd.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Type Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Mylan N.V.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Type Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. Hikma Pharmaceuticals plc
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Type Portfolio
      • 15.3.9.3. Financial Overview
    • 15.3.10. GlaxoSmithKline
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Type Portfolio
      • 15.3.10.3. Financial Overview

List of Tables

  • Table 01: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 03: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 08: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 11: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 12: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 16: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 20: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 24: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Metered Dose Inhalers Market Value Share, by Product Type, 2021
  • Figure 03: Global Metered Dose Inhalers Market Value Share, by Distribution Channel, 2021
  • Figure 04: Global Metered Dose Inhalers Market Value Share, by Disease Indication, 2021
  • Figure 05: Global Metered Dose Inhalers Market Value Share, by Region, 2021
  • Figure 06: Global Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 07: Global Metered Dose Inhalers Market Value (US$ Mn), by Manual Actuated pMDIs, 2017-2031
  • Figure 08: Global Metered Dose Inhalers Market Value (US$ Mn), by Breath Actuated pMDIs, 2017-2031
  • Figure 09: Global Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 10: Global Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 11: Global Metered Dose Inhalers Market Value (US$ Mn), by Asthma, 2017-2031
  • Figure 12: Global Metered Dose Inhalers Market Value (US$ Mn), by COPD, 2017-2031
  • Figure 13: Global Metered Dose Inhalers Market Value (US$ Mn), by Others, 2017-2031
  • Figure 14: Global Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 15: Global Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 16: Global Metered Dose Inhalers Market Value (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 17: Global Metered Dose Inhalers Market Value (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 18: Global Metered Dose Inhalers Market Value (US$ Mn), by Online Pharmacies, 2017-2031
  • Figure 19: Global Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 20: Global Metered Dose Inhalers Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 21: Global Metered Dose Inhalers Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 22: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 23: North America Metered Dose Inhalers Market Value Share (%), by Country, 2021 and 2031
  • Figure 24: North America Metered Dose Inhalers Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 25: North America Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 26: North America Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 27: North America Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 28: North America Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 29: North America Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 30: North America Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 31: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 32: Europe Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 33: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 34: Europe Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 35: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 36: Europe Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 37: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 38: Europe Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 39: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 40: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 41: Asia Pacific Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 42: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 44: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 45: Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 46: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 47: Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 48: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 49: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 50: Latin America Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 51: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 52: Latin America Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 53: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 54: Latin America Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 55: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 56: Latin America Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 57: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 58: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 59: Middle East & Africa Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 60: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 61: Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 62: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 63: Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 64: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 65: Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 66: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 67: Global Metered Dose Inhalers Market Share Analysis, by Company, 2021